Mark Hozza

Mark Hozza is a global executive who has spearheaded multimillion dollar growth within numerous industries. His approach to business is rooted in tenets of trust, transparency, and cross-functional cohesion — all of which help professionals at all levels work more efficiently and passionately toward a common goal. Mark has held senior positions at Bruker BioSpin Corporation, Tecan US Inc, and Merck & Co Inc.

Currently a consultant via his own company, Dragonfly Life Science Consulting, Mark Hozza has emerged over time as an exceptional leader. At each juncture of his diverse career, he has retained the core business practices and personal values instilled in him through his own experiences and those of his trusted mentors. However, his business approach is also flexible enough to incorporate cutting-edge technologies and adapt to change. Mark is able to maintain this approach within the constraints of highly regulated industries.

Mark earned his BS in Bioengineering at Syracuse University and his MS in Pharmacology, specializing in Cell and Molecular Biology, at SUNY Upstate Medical University. He began his career in drug development and drug discovery at Merck & Co Inc. Within five years he had risen through the ranks to a senior position, co-establishing and managing a high-throughput department within the company. This was Mark’s first experience in organizational leadership, and he was inspired by the opportunity to make a difference via infrastructural change.